A PHASE III STUDY IN LUNG CARCINOMA COMPARING HEXAMETHYL-MELAMINE (NSC-13875) TO DIBROMODULCITOL (NSC-104800)WILSON WL; VAN RYZIN J; WEISS AJ et al.1975; ONCOLOGY; SWITZ.; DA. 1975; VOL. 31; NO 5-6; PP. 293-309; BIBL. 9 REF.Article

PIPERACILLIN SODIUM (A PHASE III CLINICAL TRIAL)MACBETH WAAG.1981; J. INT. MED. RES.; ISSN 0300-0605; GBR; DA. 1981; VOL. 9; NO 5; PP. 353-359; BIBL. 1 REF.Article

FASE II-III DE ESTUDIO DEL CIS-DIAMINO DICLOROPLATINO (CISPLATINO) = ESSAI PHASE II-III DU CIS-DIAMINODICHLOROPLATINE (CISPLATINE)CORTES FUNES H; MOYANO A.1981; MED. CLIN. (BARC.); ISSN 0025-7753; ESP; DA. 1981; VOL. 76; NO 9; PP. 388-395; ABS. ENG; BIBL. 51 REF.Article

RANDOMIZED PROSPECTIVE TRIAL OF DTIC (NSC-45388) ALONE VERSUS BCNU (NSC-409962) PLUS VINCRISTINE (NSC-67574) IN THE TREATMENT OF METASTATIC MALIGNANT MELANOMABELLET RE; MASTRANGELO MJ; LAUCIUS JF et al.1976; CANCER TREATM. REP.; U.S.A.; DA. 1976; VOL. 60; NO 5; PP. 595-600; BIBL. 6 REF.Article

COMPARISON OF THE THERAPEUTIC RESPONSE OF PATIENTS WITH CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA IN RELAPSE TO VINDESINE VERSUS VINCRISTINE IN COMBINATION WITH PREDNISONE AND L-ASPARAGINASE: A PHASE III TRIALANDERSON J; KRIVIT W; CHILCOTE R et al.1981; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1981; VOL. 65; NO 11-12; PP. 1015-1019; BIBL. 11 REF.Article

MANAGEMENT OF TRIALS IN THE DEVELOPMENT OF CANCER CHEMOTHERAPY.WILLIAMS CJ; CARTER SK.1978; BRIT. J. CANCER; GBR; DA. 1978; VOL. 37; NO 3; PP. 434-447; BIBL. 24 REF.Article

LE PROGRES THERAPEUTIQUE. ANALYSE CRITIQUE DES ETUDES CLINIQUES CONTROLEES ET NON CONTROLEESALBERTO P.1978; SCHWEIZ. MED. WSCHR.; CHE; DA. 1978; VOL. 108; NO 37; PP. 1433-1437; ABS. ENG; BIBL. 16 REF.Article

CLINICAL TRIALSOF NEW DRUGS.DOLLERY CT; WADE OL; TURNER P et al.1977; J. R. COLL. PHYSICIANS LONDON; G.B.; DA. 1977; VOL. 11; NO 3; PP. 226-233; BIBL. 1 REF.Article

CONTINUATION OF PHASE II STUDY OF 1-(4-AMINO-2-METHYLPYRIMIDINE-5-YL)-METHYL-3-(2-CHLOROETHYL)-3-NITROSO UREA HYDROCHLORIDE (ACNU)SAITO T.1980; RECENT RESULTS CANCER RES.; DEU; DA. 1980; VOL. 70; PP. 91-106; BIBL. 11 REF.Conference Paper

On the design of the phase III drug trial. The example of rheumatoid arthritisHADLER, N. M; GILLINGS, D. B.Arthritis and rheumatism. 1983, Vol 26, Num 11, pp 1354-1361, issn 0004-3591Article

The ethical position of the attending physician in phase III of clinical investigationsVON EICKSTEDT, K.-W.International journal of clinical pharmacology, therapy and toxicology (1980). 1983, Vol 21, Num 10, pp 529-534, issn 0174-4879Article

MR angiography of aortoiliac occlusive disease : A phase III study of the safety and effectiveness of the blood-pool contrast agent MS-325GOYEN, Mathias; EDELMAN, Mark; KENT YUCEL, E et al.Radiology. 2005, Vol 236, Num 3, pp 825-833, issn 0033-8419, 9 p.Article

What are the reasons for negative phase III trials of molecular-target-based drugs?SAIJO, Nagahiro.Cancer science. 2004, Vol 95, Num 10, pp 772-776, issn 1347-9032, 5 p.Article

Inference of Unexpected Genetic Relatedness among Individuals in HapMap Phase IIIPEMBERTON, Trevor J; CHAOLONG WANG; LI, Jun Z et al.American journal of human genetics. 2010, Vol 87, Num 4, pp 457-464, issn 0002-9297, 8 p.Article

The importance of reporting patient recruitment details in phase III trialsWRIGHT, James R; BOUMA, Sarah; DAYES, Ian et al.Journal of clinical oncology. 2006, Vol 24, Num 6, pp 843-847, issn 0732-183X, 5 p.Article

MISOMIDAZOLE AS A RADIOSENSITIZER IN THE RADIOTHERAPY OF GLIOBLASTOMAS AND OESOPHAGEAL CANCER. PHARMACOKINETIC AND CLINICAL STUDIESTAMULEVICIUS P; BAMBERG M; SCHERER E et al.1981; BR. J. RADIOL.; ISSN 0007-1285; GBR; DA. 1981; VOL. 54; NO 640; PP. 318-324; BIBL. 20 REF.Article

M-AMSA: AN EXCITING NEW DRUG IN THE NATIONAL CANCER INSTITUTE DRUG DEVELOPMENT PROGRAMWEISS RB; CHARLES LM JR; MACDONALD JS et al.1980; CANCER CLIN. TRIALS; USA; DA. 1980; VOL. 3; NO 3; PP. 203-209; BIBL. 24 REF.Article

BRAIN TUMOR CHEMOTHERAPY: AN EVALUATION OF AGENTS IN CURRENT USE FOR PHASE II AND III TRIALSEDWARDS MS; LEVIN VA; WILSON CB et al.1980; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1980; VOL. 64; NO 12; PP. 1179-1205; BIBL. 106 REF.Article

CONTRIBUTION A L'ETUDE DE LA CHIMIOTHERAPIE DES TUMEURS SOLIDES DE LA TETE ET DU COU.TRAN VAN THUONG.1978; ; S.L.; DA. 1978; PP. (75P.); BIBL. 2 P.; (THESE DOCT. MED.; PIERRE ET MARIE CURIE PARIS VI)Thesis

OTOTOXICITY AND NEPHROTOXICITY OF AMIKACIN. AN OVERVIEW OF PHASE II AND PHASE III EXPERIENCE IN THE UNITED STATES.LANE AZ; WRIGHT GE; BLAIR DC et al.1977; AMER. J. MED.; U.S.A.; DA. 1977; VOL. 62; NO 6; PP. 911-918; BIBL. 14 REF.Article

BASIS AND RESULTS OF CHEMOTHERAPEUTIC TREATMENT OF GLIOMAS.CRAFTS DC; WILSON CB.1977; BULL. CANCER; FR.; DA. 1977; VOL. 64; NO 1; PP. 101-114; ABS. FR.; BIBL. 3 P.Article

PHASE III COMPARISON OF THE TREATMENT OF ADVANCED GASTROINTESTINAL CANCER WITH BOLUS WEEKLY 5-FU VS. METHYL-CCNU PLUS BOLUS WEEKLY 5-FU. A SOUTHWEST ONCOLOGY GROUP STUDY.BAKER LH; TALLEY RW; MATTER R et al.1976; CANCER; U.S.A.; DA. 1976; VOL. 38; NO 1; PP. 1-7; BIBL. 26 REF.Article

PHASE III STUDY OF CCNU, CYCLOPHOSPHAMIDE, ADRIAMYCIN, VINCRISTINE, AND VP-16 IN SMALL-CELL CARCINOMA OF THE LUNGETTINGER DS; LAGAKOS S.1982; CANCER; ISSN 0008-543X; USA; DA. 1982; VOL. 49; NO 8; PP. 1544-1554; BIBL. 19 REF.Article

STANDARDISATION DE L'EVALUATION D'UNE SOLUTION ET D'UNE POMMADE OPHTALMIQUE ANTIBIOTIQUEMITSUI Y; KITANO S; UCHIDA Y et al.1982; NIHON GANKA GAKKAI ZASSHI; ISSN 0029-0203; JPN; DA. 1982; VOL. 86; NO 1; PP. 20-23; ABS. ENG; BIBL. 6 REF.Article

CCNU, MELPHALAN, METHOTREXATE, AND PREDNISONE (CAMP) VERSUS CYCLOPHOSPHAMIDE, METHOTREXATE, AND 5-FLUOROURACIL (CMF) IN THE TREATMENT OF ADVANCED BREAST CANCER IN POSTMONOPAUSAL WOMENSALIMTSCHIK M; SNEL S; HAVSTEEN H et al.1980; CANCER TREATM. REP.; USA; DA. 1980; VOL. 64; NO 4-5; PP. 635-637; BIBL. 3 REF.Article